Close

William Blair Downgrades Audentes Therapeutics (BOLD) to Market Perform

November 7, 2018 5:10 AM EST
Get Alerts BOLD Hot Sheet
Price: $14.84 --0%

Rating Summary:
    1 Buy, 14 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE

William Blair analyst Raju Prasad downgraded Audentes Therapeutics (NASDAQ: BOLD) from Outperform to Market Perform.

For an analyst ratings summary and ratings history on Audentes Therapeutics click here. For more ratings news on Audentes Therapeutics click here.

Shares of Audentes Therapeutics closed at $29.56 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

William Blair